~22 spots leftby Mar 2026

Telehealth Intervention for Opioid Overdose

(BBB Trial)

Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of California, San Diego
No Placebo Group
Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?Public libraries nationwide are facing an on-premise opioid overdose crisis. Many persons with opioid use disorder (OUD) remained unhoused and profoundly hard to reach. This study innovatively develops and tests a telemedicine intervention delivered through public libraries to increase unstably housed individuals' access to bupe treatment that would prevent overdoses from occurring in the first place. The investigators will conduct a 12-week pilot 2-arm randomized controlled trial (RCT) (n=40). Research staff will recruit library patrons and randomize them to weekly telehealth at the library or in-person clinic control arms across two participating libraries in San Diego.

Eligibility Criteria

This trial is for individuals seeking treatment for opioid use disorder (OUD), regardless of their OUD and treatment history. It's open to library patrons who are not currently on buprenorphine with an active medical prescriber, or those who need a new provider. Accommodations will be made for participants with disabilities.

Inclusion Criteria

I am not currently on buprenorphine with an active prescription, or I cannot continue with my current provider.
I am interested in treatment for opioid use disorder.
I have a disability and require accommodations.
+1 more

Exclusion Criteria

Participants ineligible for FJV or the libraries will be ineligible for this study.
Persons with comorbidities or polysubstance use that needs a different level or type of care from bupe will not be enrolled in either study arm

Participant Groups

The 'Bupe by the Book' study tests if using telehealth in public libraries can improve access to buprenorphine treatment for unstably housed individuals. Participants will be randomly assigned to either weekly telehealth sessions at the library or standard in-person clinic visits over a period of 12 weeks.
2Treatment groups
Experimental Treatment
Group I: Treatment as UsualExperimental Treatment2 Interventions
Treatment as usual (in-person at clinic)
Group II: TelehealthExperimental Treatment1 Intervention
Intervention arm

Buprenorphine is already approved in United States, European Union for the following indications:

🇺🇸 Approved in United States as Buprenorphine for:
  • Moderate to severe opioid addiction (dependence)
🇪🇺 Approved in European Union as Buprenorphine for:
  • Opioid dependence

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
San Diego State UniversitySan Diego, CA
Loading ...

Who Is Running the Clinical Trial?

University of California, San DiegoLead Sponsor
San Diego State UniversityCollaborator

References